Pfizer, PFE
Pfizer Went From Covid Star to Activist Target After Stock Drop
Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its embattled chief executive face a long war against an activist that hates to lose.
Pfizer Inc (PFE) Stock: More Resilient Than It Appears
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.03% of Pfizer Inc (PFE)’s shares, while financial institutions hold 67.39%.
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note
In the latest market close, Pfizer (PFE) reached $29.08, with a -0.27% movement compared to the previous day. The stock's performance was behind the S&P 500's daily gain of 0.77%. Meanwhile, the Dow gained 0.
Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?
Activist investment fund Starboard Value took at stake in Pfizer recently, hoping to change its course. Starboard claimed that a pair of former top managers were willing to act as advisors. Those former leaders have since made it clear they aren't willing to help after all.
The PFE Conundrum: Why Pfizer Inc’s Stock Is Making Headlines Again
On Tuesday, Pfizer Inc (PFE) stock saw a decline, ending the day at $29.18 which represents a decrease of $-0.02 or -0.07% from the prior close of $29.2. The stock opened at $29.21 and touched a low of $29 during the day,
What to Expect From Pfizer's Q3 2024 Earnings Report
For fiscal 2024, analysts expect PFE to report an EPS of $2.66, up 44.6% from $1.84 in fiscal 2023 . Shares of PFE have ...
What's Happening With Pfizer Stock?
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
Hosted on MSN9d
Does Pfizer’s (PFE) 5.9% Yield Represent Rewarding Income or A Risky Bet?
Pfizer ($PFE) has long been a staple in the portfolios of income-oriented investors, especially those drawn to its consistent dividend history and ...
Pfizer Inc. (NYSE:PFE) is largely controlled by institutional shareholders who own 67% of the company
Every investor in Pfizer Inc. ( NYSE:PFE) should be aware of the most powerful shareholder groups. We can see that ...
Pfizer: A Strong Product Pipeline Could Lead To Significant Upside
Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
24/7 Wall St1d
Baby Boomers: 2 Dividend Stocks to Buy Under $30
Baby Boomers looking to put new money to work may wish to check out the broader basket of dividend stocks while interest ...
Pfizer (PFE) Gets a Hold from J.P. Morgan
J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00. The ...
Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?
With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...